Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management
Annals of Hematology · 2024
DOI: 10.1007/s00277-023-05569-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Arif Akyildiz und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey. Hauptthemen laut MEDLINE: Orbital Neoplasms, Lymphoma, Follicular, Lymphoma, B-Cell, Marginal Zone, Lymphoma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
The study analysed the clinical characteristics, treatment approaches, and survival outcomes of 97 consecutive patients with orbital lymphoma (OL) over a 25-year period at. The median age of the patients was 57.6 years, and 59.8% (n = 58) were male. Marginal zone lymphoma constitutes the most prevalent subtype, accounting for 67% of cases, whereas other common subtypes include diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, Burkitt lymphoma, and T-cell lymphomas. Unilateral involvement was observed in the majority of cases (72.3%). Common clinical presentations included mass (30.9%), swelling (26.8%), and epiphora (11.3%). Of the patients, 7.2% received rituximab alone, 14.4% received radiotherapy alone, 48.5% received chemotherapy, 27.8% received radiotherapy plus rituximab, 22.7% received radiotherapy plus chemotherapy, and 5.2% underwent surgery as the first-line treatment. During a median follow-up of 4.3 years, 15.5% of patients experienced relapse or disease progression. The 5-year and 10-year progression-free survival rates were 84.1% and 79.1%, respectively. This study contributes to our understanding of OLs and provides a foundation for further investigations in this field. Male gender, presence of B symptoms, advanced stage, secondary orbital lymphoma, aggressive histological subtype, and elevated serum lactate dehydrogenase levels were associated with poorer (either inferior or worse) progression-free survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Hacettepe University Cancer Institute, Ankara, Turkey.
- Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey. ismayilov_r@hotmail.com.
- Department of Ophthalmology, Hacettepe University Medical School, Ankara, Turkey.
- Department of Internal Medicine, Hacettepe University Medical School, Ankara, Turkey.
Zitieren
APA
Akyildiz, A., Ismayilov, R., Rustamova, N., Tokatli, M., Koc, I., Akin, S., Kiratli, H., & Barista, I. (2024). Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management. Annals of Hematology. https://doi.org/10.1007/s00277-023-05569-9
Vancouver
Akyildiz A, Ismayilov R, Rustamova N, Tokatli M, Koc I, Akin S, et al. Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management. Annals of Hematology. 2024. doi:10.1007/s00277-023-05569-9
BibTeX
@article{Akyildiz2024,
author = {Akyildiz, Arif and Ismayilov, Rashad and Rustamova, Nargiz and Tokatli, Mert and Koc, Irem and Akin, Serkan and Kiratli, Hayyam and Barista, Ibrahim},
title = {Comprehensive analysis of orbital lymphoma in a Turkish cohort: clinical characteristics, histological subtypes, treatment modalities, prognostic factors, and implications for management},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-023-05569-9}
}
EUVIMED